Fermenta Biotech Receives EU GMP Certification for Its Dahej Manufacturing Facility
Fermenta Biotech receives EU GMP certification for its Dahej manufacturing facility, Gujarat, India
Overview
Fermenta Biotech Limited, one of the largest manufacturers of vitamin D3 and a key global player, announced that its active pharmaceutical ingredient (API) manufacturing facility situated at Dahej, Gujarat, India has received a certificate of GMP compliance from the Competent Authority of Germany, following a European Union Good Manufacturing Practice (EU GMP) inspection that was conducted in March 2024. This approval reflects company’s unwavering commitment that the quality assurance is in compliance with the stringent guidelines of Good Manufacturing Practices.
From the MD: Fermenta
Prashant Nagre, managing director of Fermenta, commented on the occasion, “We are pleased with the positive outcome of the recent EU GMP inspection at our Dahej manufacturing facility in Gujarat. The certificate of GMP compliance underscores our commitment to global standards of quality, compliance and consistency in manufacturing.”
About Fermenta Biotech Limited
Founded in 1951, Fermenta Biotech Limited (FBL) possesses a growing portfolio of nutrition including Customized Premixes, Fortified Rice Kernel (FRK) and other nutritional ingredients.
Apart from its nutrition portfolio, FBL is the only manufacturer of vitamin D3 in India and a leading global player.